CASSAVA SCIENCES INC's ticker is SAVA and the CUSIP is 14817C107. A total of 184 filers reported holding CASSAVA SCIENCES INC in Q4 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,736,218 | -25.9% | 104,340 | +9.2% | 0.30% | -24.9% |
Q2 2023 | $2,343,695 | -0.8% | 95,583 | -2.5% | 0.41% | -9.6% |
Q1 2023 | $2,363,567 | +18.9% | 97,992 | +45.7% | 0.45% | +2.7% |
Q4 2022 | $1,987,156 | +199.3% | 67,270 | +323.6% | 0.44% | +199.3% |
Q3 2022 | $664,000 | -12.5% | 15,880 | -41.1% | 0.15% | -8.2% |
Q2 2022 | $759,000 | +29.1% | 26,980 | +70.4% | 0.16% | +72.8% |
Q1 2022 | $588,000 | +24.8% | 15,830 | +46.8% | 0.09% | +29.6% |
Q4 2021 | $471,000 | +48.6% | 10,780 | +111.2% | 0.07% | +39.2% |
Q3 2021 | $317,000 | – | 5,105 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bleichroeder LP | 1,739,540 | $7,150,000 | 1.87% |
SPHERA FUNDS MANAGEMENT LTD. | 615,000 | $2,528,000 | 0.32% |
Worth Venture Partners, LLC | 48,535 | $200,000 | 0.12% |
Ikarian Capital, LLC | 300,000 | $1,233,000 | 0.09% |
Orbimed Advisors | 250,000 | $1,530,000 | 0.03% |
Quinn Opportunity Partners LLC | 35,687 | $147,000 | 0.02% |
BOOTHBAY FUND MANAGEMENT, LLC | 38,356 | $158,000 | 0.01% |
Jefferies Group LLC | 80,000 | $329,000 | 0.00% |
ClariVest Asset Management LLC | 33,403 | $137,000 | 0.00% |
Renaissance Technologies | 653,759 | $2,687,000 | 0.00% |